Effect of achieved systolic blood pressure on cardiovascular outcomes in patients with type 2 diabetes: A population-based retrospective cohort study

Diabetes Care

Volumn 41, Issue 6, 2018, Pages 1134-1141

  Wan, Eric Yuk Fai ^a   Yu, Esther Yee Tak ^a   Chin, Weng Yee ^a   Fung, Colman Siu Cheung ^a   Fong, Daniel Yee Tak ^a   Choi, Edmond Pui Hang ^a   Chan, Anca Ka Chun ^a   Lam, Cindy Lo Kuen ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; COMPLICATION; DRUG EFFECT; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SYSTOLE; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SYSTOLE; TREATMENT OUTCOME;

EID: 85047471225     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc17-2443     Document Type: Article

References (61)

1. Benjamin EJ, Blaha MJ, Chiuve SE, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 update: A report from the American Heart Association [published correctionappears inCirculation 2017;135:e646;136: E196].
2. Benjamin EJ, Blaha MJ, Chiuve SE, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation 2017;135:e146-e603
3. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium, International Diabetes Federation, 2015
4. DeFronzo RA, Ferrannini E, GroopL, et al. Type2 diabetes mellitus. Nat Rev Dis Primers 2015;1: 15019
5. LastraG, SyedS, KurukulasuriyaLR, ManriqueC, Sowers JR. Type 2 diabetes mellitus and hypertension: An update. Endocrinol Metab Clin North Am 2014;43:103-122
6. Chen G, McAlister FA, Walker RL, Hemmelgarn BR, CampbellNR. CardiovascularoutcomesinFraminghamparticipantswithdiabetes: Theimportanceofblood pressure. Hypertension 2011;57:891-897
7. International Diabetes Federation Guideline Development Group. Global guideline for type 2 diabetes. Diabetes Res Clin Pract 2014;104:1-52
8. Department of Health, HKSAR. Hong Kong reference framework for diabetes care for adults in primary care settings [article online], 2010. Available from http://www.pco.gov.hk/english/ resource/professionals-diabetes-pdf.html. Accessed 12 October 2017
9. Dasgupta K, Quinn RR, Zarnke KB, et al.; Canadian Hypertension Education Program. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, andtreatment ofhypertension. CanJCardiol 2014; 30:485-501
10. American Diabetes Association. Cardiovascular diseaseandriskmanagement. Sec.9. InStandardsof Medical Care in Diabetesd2015. Diabetes Care 2018;38(Suppl. 1):S86-S104
11. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report fromthe panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-520
12. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for themanagement of hypertension in the community: A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) 2014;16:14-26
13. Go AS, Bauman MA, Coleman King SM, et al. An effective approach to high blood pressure control: A science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol 2014;63:1230-1238
14. Wright JT Jr, WilliamsonJD, Whelton PK, et al.; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control [publishedcorrectionappearsinNEnglJMed 2017; 377:2506]
15. Wright JT Jr, WilliamsonJD, Whelton PK, et al.; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-2116
16. Arguedas JA. Blood pressure targets: Are clinical guidelines wrong?. Curr Opin Cardiol 2010;25: 350-354
17. CushmanWC, Evans GW, Byington RP, et al.; ACCORD Study Group. Effects of intensive bloodpressure control in type 2 diabetesmellitus. NEngl J Med 2010;362:1575-1585
18. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-1886
19. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl JMed 2000; 342:1887-1892
20. Frieden TR. Evidence for health decision making - beyond randomized, controlled trials. N Engl J Med 2017;377:465-475
21. Kovesdy CP, Kalantar-Zadeh K. Observational studies versus randomized controlled trials: Avenues to causal inference in nephrology. Adv Chronic Kidney Dis 2012;19:11-18
22. Lau IT. A clinical practice guideline to guide a system approach to diabetes care in Hong Kong. Diabetes Metab J 2017;41:81-88
23. Wong L, Lee M, Mak H, et al. Accuracy and completeness of ICPC coding for chronic disease in general outpatient clinics. Hong Kong Pract 2010; 32:129-135
24. Wong MC, Jiang JY, Tang JL, Lam A, Fung H, Mercer SW. Health services research in the public healthcare system in Hong Kong: An analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Serv Res 2008;8:138
25. FungV, CheungN, SzetoK, Ngai L, LauM, Kong JH. Hospital Authority Clinical Vocabulary Table: The Past, the Present, and the Future. Chicago, IL, American Health Information Management Association, 2004
26. Department of Health, HKSAR. How to measure blood pressure using digital monitors [article online], 2013. Available from http://www.pco.gov .hk/english/resource/files/How-to-measure-bloodpressure-using-digital-mon.pdf. Accessed 16 October 2017
27. Royston P. Multiple imputation of missing values. Stata J 2004;4:227-241
28. Clark TG, AltmanDG. Developing a prognostic model in the presence of missing data: An ovarian cancer case study. J Clin Epidemiol 2003;56:28-37
29. Schafer JL, GrahamJW. Missing data:our view of the state of the art. Psychol Methods 2002;7: 147-177
30. Steyerberg EW, van Veen M. Imputation is beneficial for handling missing data in predictive models. J Clin Epidemiol 2007;60:979
31. Moons KG, Donders RA, Stijnen T, Harrell FE Jr. Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol 2006;59:1092-1101
32. RubinDB. Multiple ImputationforNonresponse in Surveys. Hoboken, NJ, John Wiley & Sons, 2004
33. Hong G. Marginal mean weighting through stratification: Adjustment for selection bias inmultilevel data. J Educ Behav Stat 2010;35:499-531
34. Linden A. MMWS: Stata Module to Perform MarginalMean Weighting Through Stratification. Chestnut Hill, MA, Statistical Software Components, 2015
35. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990;131:373-375
36. YoshidaH, RosanoG, ShimizuM, Mochizuki S, YoshimuraM. Gender differences in the effects of angiotensin receptor blockers on cardiovascular disease. Curr Pharm Des 2011;17:1090-1094
37. ZhaoW, KatzmarzykPT, HorswellR, et al. Blood pressure and stroke risk among diabetic patients. J Clin Endocrinol Metab 2013;98:3653-3662
38. Zhao W, Katzmarzyk PT, Horswell R, et al. Blood pressure and heart failure risk among diabetic patients. Int J Cardiol 2014;176:125-132
39. Zhao W, Katzmarzyk PT, Horswell R, et al. Aggressive blood pressure control increases coronary heart disease risk among diabetic patients. Diabetes Care 2013;36:3287-3296
40. Kontopantelis E, SpringateDA, Reeves D, et al. Glucose, bloodpressure andcholesterol levels and their relationships to clinical outcomes in type 2 diabetes: A retrospective cohort study [published correctionappears in. Diabetologia 2015;58:1142].
41. Kontopantelis E, SpringateDA, Reeves D, et al. Glucose, bloodpressure andcholesterol levels and their relationships to clinical outcomes in type 2 diabetes: A retrospective cohort study. Diabetologia 2015;58:505-518
42. Vamos EP, Harris M, Millett C, et al. Associationof systolicanddiastolicbloodpressureandall cause mortality in people with newly diagnosed type 2 diabetes: Retrospective cohort study. BMJ 2012;345:e5567
43. WanEYF, YuEYT, FungCSC, et al. Doweneed a patient-centeredtarget for systolicbloodpressure in hypertensive patients with type 2 diabetes mellitus?. Hypertension 2017;70:1273-1282
44. MesserliFH, PanjrathGS. TheJ-curvebetween blood pressure and coronary artery disease or essential hypertension: Exactly how essential?. J Am Coll Cardiol 2009;54:1827-1834
45. Davies JE, Whinnett ZI, Francis DP, et al. Evidence of a dominant backward-propagating "suction" wave responsible for diastolic coronary filling in humans, attenuated in left ventricular hypertrophy. Circulation 2006;113:1768-1778
46. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005;25: 932-943
47. Verdecchia P, Angeli F, Mazzotta G, Garofoli M, Reboldi G. Aggressive blood pressure lowering is dangerous: The J-curve: Con side of the argument. Hypertension 2014;63:37-40
48. Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP; INDANA Project Steering Committee. INdividual Data ANalysis of Antihypertensive intervention. J-shapedrelationshipbetweenblood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. AnnInternMed 2002;136:438-448
49. Bakris GL. The implications of blood pressure measurement methods on treatment targets for blood pressure. Circulation 2016;134:904-905
50. Kjeldsen SE, Lund-Johansen P, Nilsson PM, Mancia G. Unattended blood pressure measurements in the Systolic Blood Pressure Intervention Trial: Implications for entry and achieved blood pressure values compared with other trials. Hypertension 2016;67:808-812
51. Schiffrin EL, Calhoun DA, Flack JM. SPRINT proves that lower is better for nondiabetic highrisk patients, but at a price. AmJ Hypertens 2016; 29:2-4
52. Nilsson PM, Kjeldsen SE. Blood pressure goals in type 2 diabetes-assessing the evidence. Lancet Diabetes Endocrinol 2017;5:319-321
53. Mancia G, Grassi G. Blood pressure targets in type 2 diabetes. Evidence against or in favourof an aggressive approach. Diabetologia 2018;61:517-525
54. O'HartaighB, SzymonifkaJ, OkinPM. Achieving target SBP for lowering the risk of major adverse cardiovascular events in persons with diabetes mellitus. J Hypertens 2018;36:101-109
55. Sarafidis PA, Lazaridis AA, Ruiz-Hurtado G, Ruilope LM. Blood pressure reduction in diabetes: Lessons from ACCORD, SPRINT and EMPA-REG OUTCOME. Nat Rev Endocrinol 2017;13:365-374
56. Benetos A, Bulpitt CJ, Petrovic M, et al. An expert opinion from the European Society of Hypertension-European Union GeriatricMedicine Society Working Group on the management of hypertension in very old, frail subjects. Hypertension 2016;67:820-825
57. Benetos A, Rossignol P, Cherubini A, et al. Polypharmacy in the aging patient: Management ofhypertensioninoctogenarians. JAMA 2015;314: 170-180
58. Yano Y, Rakugi H, Bakris GL, et al. Ontreatment blood pressure and cardiovascular outcomes in older adults with isolated systolic hypertension. Hypertension 2017;69:220-227
59. de Boer IH, Bangalore S, Benetos A, et al. Diabetes and hypertension: A position statement by the American Diabetes Association. Diabetes Care 2017;40:1273-1284
60. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003;107:2864-2869
61. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging?. The Framingham Heart Study. Circulation 2001;103:1245-1249